Exciting times ahead for biomedical sector in Malaysia


PHILADELPHIA: Exciting times are ahead for Malaysia when one of the top Asian biopharmaceutical giants Biocon Ltd begins operations in the country next year.

Malaysia Biotechnology Corp (Biotech Corp) biomedical section senior vice-president Jay Padasian said it had taken about two years to convince the company to set up its integrated insulin plant in Malaysia.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
News , bureaus , biomedical , malaysia ,

Next In Business News

Trading ideas: MAHB, Binastra, Privasia, Capital A, IJM, Mah Sing, MPI, Cape EMS, KGW, Steel Hawk, Pavilion REIT, Carlsberg, Heineken
Oil sinks after Trump calls Putin, Zelenskiy to end Ukraine war
S&P 500 ends down on hot US inflation data
EPF denies misconduct in MAHB shares
Carlsberg Malaysia declares record dividend
Auto segment to buoy Sime Darby’s earnings
AirAsia fourth-quarter passenger volume rises 9%
MPI to dispose of properties for RM140mil
Japan seeks exemption from US tariffs
Palm oil exports to Central Asia at RM288mil

Others Also Read